Genetic variation in the estrogen metabolic pathway and mammographic density as an intermediate phenotype of breast cancer

IntroductionSeveral studies have examined the effect of genetic variants in genes involved in the estrogen metabolic pathway on mammographic density, but the number of loci studied and the sample sizes evaluated have been small and pathways have not been evaluated comprehensively. In this study, we evaluate the association between mammographic density and genetic variants of the estrogen metabolic pathway.MethodsA total of 239 SNPs in 34 estrogen metabolic genes were studied in 1,731 Swedish women who participated in a breast cancer case-control study, of which 891 were cases and 840 were controls. Film mammograms of the medio-lateral oblique view were digitalized and the software Cumulus was used for computer-assisted semi-automated thresholding of mammographic density. Generalized linear models controlling for possible confounders were used to evaluate the effects of SNPs on mammographic density. Results found to be nominally significant were examined in two independent populations. The admixture maximum likelihood-based global test was performed to evaluate the cumulative effect from multiple SNPs within the whole metabolic pathway and three subpathways for androgen synthesis, androgen-to-estrogen conversion and estrogen removal.ResultsGenetic variants of genes involved in estrogen metabolism exhibited no appreciable effect on mammographic density. None of the nominally significant findings were validated. In addition, global analyses on the overall estrogen metabolic pathway and its subpathways did not yield statistically significant results.ConclusionsOverall, there is no conclusive evidence that genetic variants in genes involved in the estrogen metabolic pathway are associated with mammographic density in postmenopausal women.

[1]  D. V. Berg,et al.  Genetic determinants of mammographic density , 2002, Breast Cancer Research.

[2]  U. Topal,et al.  Effects of hormone replacement therapy regimens on mammographic breast density: The role of progestins , 2006, The journal of obstetrics and gynaecology research.

[3]  Graham A Colditz,et al.  Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women. , 2006, Journal of the National Cancer Institute.

[4]  N. Boyd,et al.  Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence , 2008, Breast Cancer Research.

[5]  Jaana M. Hartikainen,et al.  A common coding variant in CASP8 is associated with breast cancer risk , 2007, Nature Genetics.

[6]  R. J. Brenner.  Conjugated Equine Estrogen Influence on Mammographic Density in Postmenopausal Women in a Substudy of the Women's Health Initiative Randomized Trial , 2010 .

[7]  J. Kanpittaya,et al.  Effect of estrogen-progestin and estrogen on mammographic density. , 2007, Journal of reproductive medicine.

[8]  V. Shane Pankratz,et al.  Mammographic Breast Density as a General Marker of Breast Cancer Risk , 2007, Cancer Epidemiology Biomarkers & Prevention.

[9]  C. Vachon,et al.  Pilot study of the impact of letrozole vs. placebo on breast density in women completing 5 years of tamoxifen. , 2007, Breast.

[10]  N. Boyd,et al.  Mammographic densities and breast cancer risk. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[11]  L. Eriksson,et al.  Birth weight and mammographic density among postmenopausal women in Sweden , 2009, International journal of cancer.

[12]  D. English,et al.  Is There Overlap Between the Genetic Determinants of Mammographic Density and Bone Mineral Density? , 2005, Cancer Epidemiology Biomarkers & Prevention.

[13]  S. Duffy,et al.  Interaction of dense breast patterns with other breast cancer risk factors in a case–control study , 2004, British Journal of Cancer.

[14]  Paul D P Pharoah,et al.  The admixture maximum likelihood test: a novel experiment‐wise test of association between disease and multiple SNPs , 2006, Genetic epidemiology.

[15]  T. Sellers,et al.  Mammographic density, breast cancer risk and risk prediction , 2007, Breast Cancer Research.

[16]  John L Hopper,et al.  Mammographic Density and Candidate Gene Variants: A Twins and Sisters Study , 2007, Cancer Epidemiology Biomarkers & Prevention.

[17]  Yurii S. Aulchenko,et al.  BIOINFORMATICS APPLICATIONS NOTE doi:10.1093/bioinformatics/btm108 Genetics and population analysis GenABEL: an R library for genome-wide association analysis , 2022 .

[18]  G. Colditz,et al.  Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study , 2007, Breast Cancer Research.

[19]  N F Boyd,et al.  Symmetry of projection in the quantitative analysis of mammographic images , 1996, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[20]  A. Paterson,et al.  Mammographic breast density as an intermediate phenotype for breast cancer. , 2005, The Lancet. Oncology.

[21]  Michael J. Carston,et al.  Association of Mammographic Density with the Pathology of Subsequent Breast Cancer among Postmenopausal Women , 2008, Cancer Epidemiology Biomarkers & Prevention.

[22]  T. Sellers,et al.  Can genes for mammographic density inform cancer aetiology? , 2008, Nature Reviews Cancer.

[23]  J. Manson,et al.  Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. , 1998, Journal of the National Cancer Institute.

[24]  S. Cummings,et al.  Are breast density and bone mineral density independent risk factors for breast cancer? , 2005, Journal of the National Cancer Institute.

[25]  W. Willett,et al.  A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer , 2007, Nature Genetics.

[26]  D. Hunter,et al.  Polymorphisms in Steroid Hormone Pathway Genes and Mammographic Density , 2004, Breast Cancer Research and Treatment.

[27]  G. Abecasis,et al.  Genotype imputation. , 2009, Annual review of genomics and human genetics.

[28]  Zhaohui S. Qin,et al.  Partition-ligation-expectation-maximization algorithm for haplotype inference with single-nucleotide polymorphisms. , 2002, American journal of human genetics.

[29]  John L Hopper,et al.  Mammographic density: a heritable risk factor for breast cancer. , 2009, Methods in molecular biology.

[30]  S. Cummings,et al.  Mammographic density and estrogen receptor status of breast cancer. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[31]  N F Boyd,et al.  The association of breast mitogens with mammographic densities , 2002, British Journal of Cancer.

[32]  C. Kemp,et al.  Polymorphism in CYP17, GSTM1 and the progesterone receptor genes and its relationship with mammographic density. , 2009, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[33]  Lester L. Peters,et al.  Genome-wide association study identifies novel breast cancer susceptibility loci , 2007, Nature.

[34]  References , 1971 .

[35]  C. Y. Wang,et al.  Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial. , 2005, Journal of the National Cancer Institute.

[36]  L. Le Marchand,et al.  An investigation of mammographic density and gene variants in healthy women , 2004, International journal of cancer.

[37]  Wendy J Mack,et al.  Polymorphisms in genes involved in estrogen and progesterone metabolism and mammographic density changes in women randomized to postmenopausal hormone therapy: results from a pilot study , 2005, Breast Cancer Research.

[38]  A. Uitterlinden,et al.  Polymorphisms in the Estrogen Receptor α Gene and Mammographic Density , 2005, Cancer Epidemiology Biomarkers & Prevention.

[39]  P. Ridker,et al.  The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women. , 2006, Journal of the American College of Cardiology.

[40]  O. Nalcioglu,et al.  Does breast density show difference in patients with estrogen receptor-positive and estrogen receptor-negative breast cancer measured on MRI? , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[41]  David Tritchler,et al.  Heritability of mammographic density, a risk factor for breast cancer. , 2002, The New England journal of medicine.

[42]  Graham A. Colditz,et al.  The Nurses' Health Study: lifestyle and health among women , 2005, Nature Reviews Cancer.

[43]  Woo Kyung Moon,et al.  Computer-aided detection in digital mammography: comparison of craniocaudal, mediolateral oblique, and mediolateral views. , 2006, Radiology.

[44]  Christopher A. Haiman,et al.  Choosing Haplotype-Tagging SNPS Based on Unphased Genotype Data Using a Preliminary Sample of Unrelated Subjects with an Example from the Multiethnic Cohort Study , 2003, Human Heredity.

[45]  M. Pike,et al.  Greatly increased occurrence of breast cancers in areas of mammographically dense tissue , 2005, Breast Cancer Research.

[46]  Martin J Yaffe,et al.  Mammographic density: a hormonally responsive risk factor for breast cancer , 2006, The journal of the British Menopause Society.